CymaBay Therapeutics Inc. (CBAY)
CBAY has a market cap or net worth of $234.56 million. The enterprise value is $125.22 million.
The next earnings date is Thursday, August 11, 2022, after market close.
|Estimated Earnings Date||Aug 11, 2022|
CBAY has 84.68 million shares outstanding. The number of shares has increased by 27.35% in one year.
|Shares Change (YoY)||+27.35%|
|Shares Change (QoQ)||+13.64%|
|Owned by Insiders (%)||0.39%|
|Owned by Institutions (%)||79.38%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 13.68, with a Debt / Equity ratio of 0.74.
|Debt / Equity||0.74|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -92.30%, which is considered low. The company has a ROIC of -85.00%.
|Return on Equity (ROE)||-92.30%|
|Return on Assets (ROA)||-62.40%|
|Return on Capital (ROIC)||-85.00%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$1.70M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -36.47% in the last 52 weeks. The beta is 1.08, so CBAY's price volatility has been similar to the market average.
|52-Week Price Change||-36.47%|
|50-Day Moving Average||2.20|
|200-Day Moving Average||2.82|
|Average Volume (30 Days)||790,070|
Short Selling Information
The latest short interest is 3.35 million, so 3.95% of the outstanding shares have been sold short.
|Short % of Shares Out||3.95%|
|Short % of Float||5.38%|
|Short Ratio (days to cover)||5.45|
|Earnings Per Share (EPS)||-$1.32|
The company has $188.56 million in cash and $79.22 million in debt, giving a net cash position of $109.34 million or $1.29 per share.
|Cash & Cash Equivalents||188.56M|
|Net Cash Per Share||$1.29|
|Book Value Per Share||1.27|
In the last 12 months, operating cash flow was -$74.23 million and capital expenditures $7,000, giving a free cash flow of -$74.23 million.
|Operating Cash Flow||-74.23M|
|Free Cash Flow||-74.23M|
|FCF Per Share||n/a|
Dividends & Yields
CBAY does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for CBAY is $10.09, which is 264.26% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||264.26%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|